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ABSTRACT
FACTORS INFLUENCING THE OXIDATION OF
LIPOPROTEINS AND PLASMA
By
Yanshan Ma
The hypothesis that antioxidant vitamins (ascorbate and tocopherols)
along with urate protect blood plasma lipids from oxidation w as tested. Dietary
fat is also an Important factor Influencing plasma lipid peroxidation. The purpose
of this study w as to Investigate the role of plasma antioxidants and dietary fat on
low density lipoprotein (LDL) and plasma lipid oxidation.
In the first part of this study, we oompared the ability of urate and ascor
bate to protect human LDL from in vitro oxidation. LDL oxidation w as Initiated by
15 mM of a water soluble azo-inttlator In the presence or absence of ascorbate
or urate. The rate of lipid hydroperoxide (LOOH) formation w as increased after
the LDL tocopherols were totally consumed, I.e., after the lag phase. Urate (50
pM) w as more effective than ascorbate (50 pM) In extending the lag phase.
Moreover, urate w as consumed more slowly than ascorbate under identical
oxidation conditions. The combination of 25 pM ascorbate and 25 pM urate was
more effective in extending the lag phase than ascorbate alone but less effective
than urate alone. An empirical mathematical model was developed to describe
the oxidation kinetics of LDL tocopherols.
In the second part of this study, we studied the role of dietary fat and
dietary a-tocopherol (a-toc) levels on rat plasma oxidation. The fatty ad d
composition of plasma w as found to be modulated by the type of dietary fat.
Neither dietary fat nor a-toc Influenced the plasma levels of water soluble
antloxldants (ascorbate, urate and sutfhydryl content). Rat plasma w as oxidized
either by a water soluble azo-inttlator (25 mM) or a lipid soluble azo-lnltlator (10
mM). In both cases, the rate of LOOH formation In plasma from rats fed butter
oil diets w as markedly suppressed compared to the plasma from rats fed com oil
diets. When oxidation w as initiated by a llptd soluble azo-lnltlator, plasma from
rats fed a-toc supplemented diets showed higher LOOH levels than plasm a from
rats fed a-toc deficient diets. Surprisingly, when oxidation w as Initiated by water
soluble azo-lnltlator, tocopherol appeared to act a s a pro-oxidant.
The results suggest that urate may be more significant than ascorbate In
delaying the consumption of tocopherols In human LDL and that low dietary
PUFAs levels are more Important In preventing the in vitro oxidation of plasma
lipids than high dietary levels of a-tocopherol.
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CHAPTER 1
Introduction
Oxidation of Lipoproteins and Atherosclerosis
Lipoproteins are a group of Ifpld transport macromolecules that consist of
a core of hydrophobic lipids surrounded by polar llptds and apoproteins. The
major classes of lipoproteins, In increasing order of density, are chylomicrons,
very low-densfty lipoproteins (VLDL), low-denslty lipoproteins (LDL) and high
density of lipoproteins (MDL). LDL, the major cholesterol-bearing lipoprotein in
human plasm a is a large spherical particle. Its hydrophobic core consists of
cholesteryt e ster in which each cholesterol molecule is attached by an ester
linkage to a long-chain fatty acid. The surrounding amphlpathlc monolayer
contains phospholipids with their head groups on the outer surface, unesterified
cholesterol molecules and apoprotein B-100 which stabilizes LDL in the
aqueous environment. LDL contains large am ounts of poly-unsaturated fatty
acids (PUFAs), i.e., C18:2n6, C18:3n3 and C20:4n6 which render LDL
susceptible to peroxldatioa
Oxidative modification of LDL is implicated in the pathogenesis of
atherosclerosis as recently proposed by Dr. Steinberg and his colleagues
[Steinberg et al., 1989]. Atherosclerosis is a complicated pathologic process in
which environmental, nutritional, metabolic and genetic factors play important
roles. Most vascular disease, such a s cardiovascular and cerebrovascular
d iseases are primarily caused by atherosclerosis which account for the largest

percentage of all deaths in W estern society [Working group of atherosclerosis
of the National Heart, Lung, and Blood Institute, 1981]. The major pathological
change in atherosclerosis is the formation of atherom as or atherosclerotic
plaques, which c au se serious injury to the arterial wall and severe narrowing of
the arterial lumen. It is not known how this process initially starts,
atherosclerotic plaques, however, are generally found at branch points or
bifurcations in large-sized and medium-sized arteries where fluid mechanical
sh ear stre ss is high [Schwartz et al„ 1991]. T he enhanced permeability of the
endothelial lining facilitates accumulation of LDL in the subendothelium space
which is thought to be the first step in atherogenesis [Meyers and Maloley,
1993]. It w as proposed that subendothelial accumulation of LDL may result
from two processes: (1) the increased gaps between adjacent endothelial celts
caused by elevated serum LDL levels allow LDL to leak into the
subendothellum; (2) a specific hlgh-affinHy receptor on the endothelial cells
which c au se s LDL to reach the subendothelial space [Steinberg, 1983]. A
num ber of studies have shown that LDL can be oxidized by incubation with
cultured endothelial celts, smooth muscle celts and m acrophages, all of which
are normally found in the artery wait [Morel et at., 1984; Henriksen et al., 1983;
Stelnbrecher et al., 1984; Parthasarathy et al., 1986a]. T hese findings
suggested that once LDL reaches the subendothelial sp ace it can be oxidatively
modified by endothelial cells, monocytes and m acrophages. Since plasma
contains antioxidants capable of inhibiting LDL oxidation, the oxidation process

in vivo most likely takes place In the subendothelial sp ace rather than In plasm a

[Chisolm, 1891].
Although the etiology of atherosclerosis Is not completely understood,
increasing evidence suggests that oxidative dam age to LDL plays an important
role. Oxidatively modified LDL (OM-LDL) Is more atherogenic than native LDL
for a number of reasons (see F1g.1). OM-LDL is a chemo-attractant for blood
monocytes which adhere to the endothelium and then penetrate to the
subendothelium through gaps between endothelial cells [Quinn e t al., 1987].
Monocyte adhesion to endothelial cells is thought to be one of the earliest
events in the atherogenesis. Within the subendothelial space, monocytes
differentiate to m acrophages through an undefined process [Ross, 1986]. OMLDL also inhibits th e motility of m acrophages in the artery wall and therefore
Inhibits the ability of m acrophages to leave the subendothelial sp ace [Quinn et
al„ 19851. OM-LDL is cytotoxic for cultured endothelial cells [Morel et al., 1983;
Hennlg and Chow, 1988] and injury to endothelial cells m ay Induce platelet
aggregation, adherence, and activation at the dam aged site [Schwartz et al.,
1991; ArdUe et al., 1989; Bruckdorfer, 1989]. In addition, endothelial dam age
allows the blood elem ents to enter the subendothelium sp ace thus facilitating
the atherogenic process. Moreover, OM-LDL can directly activate platelets and
cau se secretion of platelet granules [Bruckdorfer, 1989]. It w as also reported
that OM-LDL Induced by Cu3* is more effective than native LDL In sensitizing
platelets [Ardlie e t al„ 1989]. OM-LDL is rapidly taken up by the nonregulated
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Figure 1. A schem atic outline showing the possible m echanism s whereby
oxidatively modified LDL (OM-LDL) is more atherogenic than native LDL

scavenger receptor on m acrophages [Henriksen et al., 1981; Pahhasarathy et
al., 1985]. The scavenger receptor Is distinct from the native LDL receptor and
is neither saturated nor down-regulated by high concentration of OM-LDL
[Goldstein e t al., 1979]. Only chemically modified forms of LDL, such a s
acetylated, malondialdehyde-conjugated, and oxidized LDL, but not native LDL,
are recognized by the scavenger receptor [Steinberg et al., 1989]. A recent
study suggests that there Is another type of receptor on m acrophages that
recognizes only oxidized LDL but not other chemically modified forms of LDL
[Sparrow et al., 1989]. M acrophages take up OM-LDL a t a rate 3-10 times
greater than native LDL [Henriksen et al., 1981].

M acrophages incubated with

OM-LDL accum ulate large am ounts of cholesteryl esters and becom e lipidengorged loam * cells. Foam cells a re major components of fatty streaks which
are thought to be the precursors of fibrous atherosclerotic plaques. OM-LDL
can also be cytotoxic to m acrophages and foam cells, therefore damaging
th ese cells. The Intracellular OM-LDL, lysosomal enzym es and free radicals
released from necrotic foam cells can further dam age adjacent cells and
interstitial com ponents which can lead to an Inflammatory process [Meyers and
Maloley, 1993].
R ecent studies suggest that OM-LDL Is present in vivo. Immunocytochemical techniques have shown that antibodies against OM-LDL recognize
antigens In atherosclerotic lesions but not In normal sections of arteries
[Haberiand et al., 1988; Palinskl, 1989,; Rosenfeld et al., 1990; Pal inski et al.,

1990]. Other convincing evidence for the presence In vivo of OM-LDL Is that
antioxidants such a s probucol (Carew et al., 1987; KHa et al., 1987] or butytated
hydroxytoluene pjorkham et al., 1991] can inhibit the progression of
atherosclerotic lesions in LDL receptor-deficient rabbits (WHHL rabbits) of
cholesterol-fed rabbits. Probucol is able to lower plasm a cholesterol levels and
this effect alone may delay the development of atherosclerosis In the WHHL
rabbits. Therefore, in the c a se of the probucol study, the plasm a cholesterol
levels in both the control group and the probucol-supplemented group were
adjusted to b e the sam e so that the cholesterol-lowering effect of probucol
could b e balanced o u t It w as shown that probucol inhibits the uptake and
degradation of LDL In atherosclerotic lesions but not In normal arteries [Carew
et al., 1987]. The findings that patients with atherosclerosis showed higher
serum levels of lipid peroxides also suggest an in vivo role for OM-LDL
[Stringer et al., 1989; Liu et al., 1992; Plachta et al., 1992].

Mechanism of Uoid peroxidation
Upid peroxidation may b e Initiated by a primary free radical which Is a
molecule or molecular fragment with an unpaired electron. In aerobic biological
system s, the most important free radicals are superoxide anion (0 2*), peroxyl
radicals (HOO), hydroxyl radicals (HO), alkyl radicals (R ) and lipid peroxyl
radicals derived from PUFAs (LOO) [Burton and Traber, 1990]. LDL contains
large amount of PUFAs, i.e., C18:2n6, C18:3n3 or C20:4n6, which are very
susceptible to lipid peroxidation. The mechanism of LDL lipid peroxidation is

likely to resem ble the process that has been studied using artificial lipid
substrates. As shown In Fig. 2, lipid peroxidation is initiated when a radical
Initiator abstracts a hydrogen atom from a PUFA segm ent (LH) present In the
LDL (Initiation event). The resulting carbon-centered lipid radical stabilizes by
isomerization to a conjugated diene through double bond rearrangem ent. The
lipid radical containing conjugated diene reacts rapidly with molecular oxygen to
form a lipid peroxy radical (LOO). In the a b sen ce of antioxidants, the peroxy
radical will abstract a hydrogen atom from an adjacent PUFA segm ent to yield
a lipid hydroperoxide (LOOH) and another fatty a d d carbon-centered radical.
The new carbon-centered radical can then continue the uncontrolled chain
reaction over again, This propagation phase can be repeated m any times
prodded that molecular oxygen and unoxidized PUFA segm ents are present in
the reaction system. Therefore, one initiation step can trigger num erous fatty
a d d s to form lipid hydroperoxides. Furthermore, the reaction may further
accelerate b ecause lipid hydroperoxides can b e decom posed by transition metal
Ion-catalyzed reactions and becom e radicals, such a s lipid peroxyl radicals and
alkoxyl radicals. T hese radicals can further initiate and propagate the lipid
peroxidation. The termination of the propagation cycle occurs when peroxy
radicals interact each other and interact with various free radical scavengers
(e.g., antioxidants) resulting In non-radical, stable products.

Antioxidants andU pldO xldation
Plasm a contains an array of antioxidants that can prevent the initiation of
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Figure 2. Mechanism of ilpid peroxidation.

termination

chain reaction or Inhibit the extent of lipid peroxidation by trapping free radicals.
T hese antioxidants include protein sutfhydryl groups, enzym es (superoxide
dism utase, selenium-dependent glutathione peroxidase, catalase) and
non enzymatic antioxidants, such a s vitamin E, 8-carotene, lycopene, vitamin C
(ascorbic ad d ), glutathione and uric a d d . T hese antioxidants constitute a
defense system against free radical dam age.
Vitamin E is the major lipid soluble, chain-breaking antioxidant in plasm a
[Burton et a)., 1983; Ingold et al., 1987]. Naturally occurring vitamin E has eight
different forms: alpha-, beta-, gamma-, delta-tocopherols and alpha-, beta-,
gamma-, ddta-tocotrienois [Kayden and Traber, 1993]. All of the tocopherols
have a chromanoi ring and a phytyl tali. They are dasslfied based on the
num ber and position of methyl groups on the rings. Tocotrienols differ from
tocopherols in their unsaturated tails. The major dietary sources of vitamin E
are cereals, nuts and legum es [Hodges, 1979]. Untike other fat-soluble
vitamins, vitamin E h as no specific transport protein in plasm a, but rather is
carried by lipoproteins, particularly HDL and LDL [Behrens and Madere, 1985;
Ogihara et at., 1988; Clevidence and Lehmann, 1989]. The major forms of
dietary vitamin E in hum ans are alpha- and gamma-tocopherols (Fig. 3). The
concentration of alpha-tocopherol in human plasm a is usually 2 to 3 tim es
higher than that of gamma-tocopherol. Alpha-tocopherol is the m ost potent
antioxidant of the tocopherols. It reacts more quickly with peroxyl radicals than
do other tocopherols or PUFAs [Burton and Ingold, 1986]. Kinetic studies using
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Figure 3. AJpba-tocopberol and gamma-tocopherol are major forms of vitamin E
in human p lasm a They differ In the number and position of methy groups on
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synthetic lipid substrates have shown that one molecule of tocopherol
scavenges two molecules of peroxyl radicals [Yamamoto et al.,1984; Nlkf et al.,
1984; Burton and Ingold, 1981]. As shown In Flg.4, alpha-tocopherol donates
its phenolic hydrogen atom to a peroxyl radical and converts It to lipid
hydroperoxide. The resulting tocopheroxyl radical is resonance-stabilized;
therefore, it normally Is not thought to participate in chain propagation but
scavenges another peroxyl radical thereby terminating the chain reaction.
Several lines of evidence indicated that vitamin E, whether supplemented in
diets or added in vitro, Is able to inhibit oxidation of LDL [Stone e t al„ 1986;
Stone, 1968; DIeber-Rotheneder e t al., 1991; Jlalal and Grundy, 1992; Princen
et al., 1992; Esterbauer et al., 1991]. Je su p and his colleagues [Jesup et a l,
1990] have shown that all the endogenous alpha-tocopherol in LDL must be
oxidized before the LDL Is converted into a form of OM-LDL capable of rapid
uptake by m acrophages In tissue culture. Recent studies suggest that one LDL
particle, on average, contains six alpha-tocopherol molecules and one thousand
molecules of PUFA [Janero, 1991]. One molecule of vitamin E Is estim ated to
protect about three thousand PUFA molecules against free radical injury [Gey
e t al., 1987]. This protection, however, lasts for onfy a relatively short time.
Moreover, It Is very likely that LDL oxidation in vivo would be initiated by
radicals generated In the aqueous phase. W ater soluble antioxidants in plasm a
quench aqueous free radicals and should thereby inhibit LDL oxidation and the
consumption of LDL tocopherols.
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+ LOOH

Figure 4. Vitamin E (a-tocoptwof) is a major lipid solubla antioxidant.

Each

molecule of a-tocophtro) can scavenge two molecules of peroxyl radicals
(LOO*) and convert them into lipid hydroperoxides (LOOH) or stable product.
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Vitamin C (ascorbate) [3 a water soluble antioxidant that effectively
protects plasm a lipids from peroxldative dam age caused by aqueous free
radical species [Frel et al„ 1988; Frel et al., 1989; Frel, 1991; Niki, 1991]. Each
ascorbate molecule can terminate 0.6 free radicals [Doba et al., 1985]. It was
shown that ascorbate quenches aqueous peroxyl radicals with a fast rate
constant so that m ost initiating free radicals can be trapped before they can
diffuse into the lipid phase [Nik!, 1991]. Moreover, there is evidence suggesting
that ascorbate can regenerate tocopherol from the tocopheroxyl radical in LDL
at the llpfd-water Interface (Sato e t al., 1990; Kagan e t al., 1992; Kafyanaraman,
1992]. Therefore, ascorbate and vitamin E m ay act together In preventing LDL
oxidation.

C H ,O H
H ► C ^ OH

HN
NH
O

HO

OH

L-Ascorbic Acid

Uric Acid

llrfc acid (urate at physiological pH), a metabolic product of purine
degradation, Is also an Important antioxidant in human plasm a and tissues
[Frei,1991; Ames et al., 1981; Cutler, 1991]. Ames et al. proposed that uric
acid may have replaced som e of the antioxidant functions of ascorbic a d d since
hum ans have lost the ability to synthesize ascorbate during evolution [Ames et
al., 1981]. The loss of uricase activity, an enzyme that converts urate to form
ailantoin, a s wett a s the development of a n active kidney reabsorption system
for urate allows hum ans to have 10 times higher serum concentration of urate
than most other mammals [Roch-Ramel, 1978]. Urate is capable of Inhibiting
lipid peroxidation, In part, by chelating Iron and copper [Rice-Evans and
Bruckdorfer, 1992]. Earlier studies had reported that urate can scavenge
singlet oxygen and oxy-haem oxidants [Simon and Van Vunakis, 1964; Howell
and W yngaarden, 1960]. Urate can also protect the stability of linolelc a d d
[Matsushita et al., 1963] and the Integrity of erythrocyte m em brane [Kellogg and
Fridovich, 1977].
There Is, however, little information concerning the comparative ability of
urate and ascorbate to inhibit LDL oxidation. This is an Important issue since
plasm a levels of urate (300*395 pM) In hum ans are about five to ten times
higher than plasm a levels of ascorbate (30-50 pM). In the first part of this
research, we compared the ability of urate to protect hum an LDL from in vitro
oxidation with that of ascorbate. W e also studied the combined effect of these
two antioxtdants in protecting LDL from oxidation. The kinetics of LDL oxidation
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w as m easured In the absence of water-soluble antioxidants, in the presence of
equimolar concentrations (50 pM) of either urate or ascorbate or In the
presence of 25 pM urate combined with 25 pM ascorbate. An empirical
mathematical model w as also developed to describe th e oxidation kinetics of
LDL alpha-tocopherol and gamma-tocopheroi in the presence or ab sen ce of
urate or ascorbate.
Dietary Fat and Plasm a Oxidation
In addition to antioxidants, dietary fat-type may also b e an important
factor influencing lipid peroxidation. It is generally accepted that hum an health
can be optimized by the long-term consumption of diets with PUFAs substituting
for saturated fatty a d d s (SFAs), since PUFAs have been dem onstrated to lower
plasm a cholesterol levels [Mattson and Grundy, 1985; Grundy, 1975; Ahrens et
al., 1957]. PUFAs, however, contain more double bonds and are, therefore,
more susceptible to lipid peroxidation than SFAs or m onounsaturated fatty a d d s
(MUFAs). Fatty a d d autoxldation requires at least two double bonds (I.e., a
divinyl m ethane structure, CHafCH-CH*)^ and the rate of oxidation increases
with the degree of polyunsaturation.
The fatty a d d composition of plasm a lipids is strongly Influenced by the
fatty a d d composition of dietary fat [HIral e t at., 1984; Parthasarathy et al.,
1990]. Hlrai et al. showed that plasm a from rats fed a 1% cholesterol diet with
20% butter oil had lower ratio of PUFA to SFA com pared to plasm a from rats
fed identical diets but with either 20% cod liver oil or 20% w heat germ oil

replacing the butter oil [Hirai et al„ 1984]. Studies in African green monkeys
showed that a diet rich in linoleic acid resulted In llnolelc add-enriched LDL
[Rudel et al., 1986]. Diets with a high PUFA content should result In plasm a
lipids with a high PUFA content and a greater susceptibility to lipid peroxidation.
LDL from rabbits fed a diet rich in linoleic a d d containing high PUFA content is
more susceptible to oxidation than LDL from rabbits fed a diet rich In oleic a d d
containing high MUFAs [Parthasarathy et al., 1990]. Moreover, oxidative stress
caused by PUFA-rich diets should be amplified by d efld en d es of plasm a
antloxldants, such a s vitamin E, a major lipid soluble antioxidant Hafeman and
Hoekstra have shown that rats fed cod liver oil (high PUFA) and vitamin E
deficient diets exhale more ethane, a product formed during lipid peroxidation,
than rats fed a similar diet but rich in lard (very low PUFA) [Hafeman and
Hoekstra, 1977]. A recent study in hum ans show ed that a fish oil diet without
vitamin E supplementation results In LDL more susceptible to in vitro oxidation
than a fish oil (Set supplemented with vitamin E [Oostenbrug, 1993]. There is,
however, little Information on th e potential influence of dietary fat and dietary
vitamin E on plasm a lipid oxidation.
Lipid peroxidation and vitamin E deficiency are known to influence the
activity of plasm a lecithin:cho!esterol acyttransferase (LCAT) and phospholipase
As [Pappu et a)., 1978]. T hese enzym es a re important In the production of
plasm a fysoledthln. Lysoiedthln Is chemotactic for human monocytes. It
inhibits the mobility of m acrophages in vitro and may, therefore, play a role in

foam celt formation [Parthasarathy et al., 1986; Quinn e t al„ 1988]. It w as
shown that lysolecithin Impaired the endothelium-dependent relaxation of the
vasculature [Schwartz e t al., 1986]. During LDL oxidation in vitro there Is an
extensive hydrolysis of phosphatidylcholine at the 2-position through
phosphollpase Aj resulting in increased lysolecithin formation [Steinbrecher et
al., 1984]. Pappu et a), found that vitamin E deficiency in rats caused a
dramatic reduction In plasm a LCAT activity and an activation of phosphollpase
As In liver mitochondria. The plasm a level, however, of lysolecithin w as not
m easured in their study.
A few lines of evidence, recently, suggested that ethanolamine
ptasmalogens, a group of glycerophosphollplds in plasm a lipids, m ay play a role
in modulating oxidative stress to plasm a lipids. In particular, ethanolamine
plasmalogen (1-alk-1-enyl-2-acylglycerophosphoethanolamlnes or EtnPm) may
function a s a n antioxidant since th e se lipids have a vinyl ether linkage that can
scavenge reactive oxygen species (Zoeller e t al., 1988; Vance, 1990]. This
hypothesis, however, h a s not been critically tested. Moreover, It Is not known
how dietary fat and dietary vitamin E deficiency Influence the lipid composition
of plasm a phospholipids, especially the lysolecithin and EtnPm.
In th e second part of this research, w e investigated the Interaction
betw een dietary PUFA content and dietary vitamin E intake in modulating the in
vitro oxidation of plasm a, a s well a s the lipid composition of plasm a

phospholipids. Rat plasm a oxidation was initiated by azo-inttlator. Azo-Inftiators

are particularly useful for quantitative studies of oxidation kinetics b ecause they
decom pose to yield initiating free radicals a t known and constant rates. Two
types of azo-inttiators were used In rat plasm a oxidation. One is w ater soluble,
I.e., 2,2*-azobte (2-admidinopropane) HCL (ABAP) and it generates free radicals
In the aqueous environment; the other is lipid soluble,

I.e., 2,2’ azobis-

(2,4-

dimethylvaleronitrile) (AMVN) and It generates free radicals within the lipid
domain.
An animal model w as utilized to test the following hypotheses: (1) plasm a
isolated from rats fed a com oil diet (CO) high in PUFA would be m ore
susceptible to in vitro lipid peroxidation than plasm a isolated from rats fed a
butter oil diet (BO) low in PUFA; (2) plasm a from rats fed a vitamin E deficient
diet would b e more susceptible to in vitro lipid peroxidation than plasm a from
rats fed an identical diet but supplemented with vitamin E; (3) plasm a from rats
fed vitamin E deficient diets (CO-E or BO-E) would have a higher level of
lysolecithin and a lower content of plasmaiogen.

CHAPTER 2
Materials and Methods
Part I - The Influence of Plasm a Antioxidants on the Oxidation

Kinetics of Human Lipoprotein

Overall Experimental Deslon
Human LDL w as Isolated from Red C ross plasm a by step-wise density
ultracentrifugation. The purified LDL was subjected to In vitro oxidation at 30°C
with an Oa saturated solution containing 15 mM water soluble azo-lnftlator, or
ABAP. In parallel experiments, 50 pM ascorbate and 50 pM urate w ere added
to the oxidation solution respectively. An additional experiment w as performed
In which 25 pM ascorbate combined with 25 pM urate w as present in the
oxidation solution. The consumption of LDL vitamin E (alpha-tocopherol and
gamma-tocopheroQ and formation of lipid hydroperoxide, a s well a s the
disappearance of ascorbate and urate were m easured a s a function of time.

Chemicals
2,2'-Azobls (2-amtdinopropane) HQ (ABAP) w as obtained from
Polysciences, Inc. (Warrington, PA) and stored a t 4°C. Ascorbic a d d (vitamin
C) was purchased from Fluka Biochemika (Switzerland). Ethylenediamlnetetraacetic a d d (EDTA), urate and propyl gallate were obtained from Sigma
Chemical Company (S t Louis, MO). Sodium dodecyl sulphate (SDS) w as
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purchased from Hoefer Scientific Instruments (San Francisco, CA). Butylated
hydroxy-toluene (BUT) w as obtained from Aldrich Chemical Company, Inc
(Milwaukee, Wl). Sodium chloride (NaCI), potassium bromide (KBr), HPLC
grade methanol and hexane were purchased from Fisher Scientific (Fair Lawn,
New Jersey). Absolute ethyl alcohol w as obtained from Florida Distillers
Company (Lake Alfred, FL). Tocol w as a generous gift from Hoffman-La Roche
Chemical Co (Nutley, NJ). All chemicals were used a s they cam e without
further purification.
Lipoprotein preparation
Human plasm a (1.0 mg EDTA/mQ collected from Individual healthy
donors w as obtained from American Red Cross. LDL (density range 1.019
g/ml-1.063 g/mt) w as Isolated by step-wise density uttracentrifugation using a
Sorvall OTD-65B uttracentrifuge a s previously described [Stone, 1975]. Plasm a
w as centrifuged at 54,454 x g at 15 °C for 18 hrs In a Beckman type 30 rotor.
Chylomicron and VLDL (top layer) w ere removed. The density of the remaining
plasm a containing LDL and HDL w as adjusted to 1.063 g/ml by adding solid
KBr. After centrifuged at 4°C for 24 hr at 267,812 x g in a Sorvall H865.1 rotor,
the top LDL layer w as collected. LDL was further purified by gel permeation
chromatography on a Sepharose CL-4B (Pharmacia Biotech Inc., Piscataway,
NJ) column eluted with 0.15 M NaCI with 0.25 mM EDTA adjusted to pH 7.4.
in addition to removing small am ounts of albumin, this chromatographic step
also removed any remaining ascorbate and urate from the LDL T he LDL
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fractions w ere pooled, filtered through a 0.45 pm Acrodisc filter and stored at
4°C under nitrogen until used (within one week).

SDS-Poh/acrvlamlde Gel Electrophoresis
The LDL purity w as checked by SDS-polyacrylamide gel electrophoresis
SDS-PAGE). LDL fractions eluted by get permeation chromatography w ere
used for electrophoresis. The gel electrophoresis w as performed according to
the method of Laemmli [Laemmli, 1970] using a 7.5% acrytamide gel at a
constant current of 20 mA in a Mighty Small II slab gel electrophoresis unit
(Hoefer Scientific Instruments, S an Francisco, CA). Gels w ere stained with
Coom assie Blue R-250 and then destained with a solution containing 10%
methanol an d 7.5% acetic a d d . SDS-PAGE indicated a single apotipoprotein
polypeptide with an electrophoretic mobility Identical to that of apoBIOO.

Determination of Protein Concentration
LDL protein w as determined by a modification of the Lowry method
[Markweil, e t al„ 1978] using bovine serum albumin a s standard.

Upooroteln Oxidation
Five different plasm a donors were used and the LDL from each donor
w as independently subjected to the oxidation. Dialysis tubing w as boiled and
thoroughly rinsed with 0.1 mM EDTA to rem ove any trace metals. A 3.0 ml
aliquot of LDL (0.5*1.0 mg protetn/ml) w as placed inside the dialysis tubing with
a protruding length of mtcrobore teflon tubing a s shown in Figure 5. After

no ascorbate
or urate

50 pM ascorbate

50 pM urate

25 pM ascorbate
+ 25 |iM urate

30 °C

Figure 5. Human LDL oxidation system s in the absence or presence of water
soluble antioxidants. LDL was placed inside the dialysis tubing which w as placed
in a beaker. In each oxidation system , both LDL and the dialysate contained 15
mM ABAP.

sealing, the dialysis tubing with LDL w as placed In a beaker containing 200 ml
of 0.15 M NaCt/0.25 mM EDTA with 15.0 mM of a w ater soluble azo-inftlator
(azobIs-2-amldtnopropane HCL or ABAP) at pH 7.4. ABAP w as also added to
the LDL sam ple before the dialysis tubing w as sealed giving a final
concentration of 15.0 mM. A second parallel LDL oxidation system w as
assem bled but ascorbate (50 pM final concentration) w as added to both the
dialysate and the LDL sample. Similarly, a third parallel LDL oxidation system
had 50 pM urate. The stock ascorbate or urate solutions w ere m ade
Immediately before each oxidation experiment using deaerated pH 7.4/0.15 M
NaCt/ 0.25 mM EDTA solution. To study the combined effect of ascorbate and
urate on LDL oxidation, an additional experiment w as performed using LDL
from a single additional donor. In addition to the 3 oxidation system s described
above, a fourth LDL oxidation system w as se t up in which both of the dialysate
and LDL sam ple contained both 25 pM ascorbate and 25 pM urate.
The oxidation experiment w as initiated (at 30 °C) immediately after the
ABAP w as added to LDL by continuously bubbling filtered air through a 60 pm
pore g as diffusing stone In each beaker. At each time point an aliquot of the
LDL w as withdrawn from the dialysis bag in each beaker (via the microbore
tubing) and Immediately assay ed for lipid hydroperoxides (in triplicate) and
tocopherols. An aliquot of the dialysate w as also withdrawn from each beaker
and used to determine the concentration of urate and ascorbate.
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Lipid Hydroperoxide Measurement
Liptd hydroperoxide levels w ere assayed using a methylene blue
derivative (10-N-methytearbamoyl-3,7-dimethylamino-10 H-phenothiazine or
MCDP). The chemical mechanism of this a ssa y is illustrated in Figure 6. In the
presence of hemoglobin (a reaction catalyst), lipid hydroperoxides
stoichiometricalty react with the MCDP to produce methylene blue [Tatelshi et
al., 1987; Ohlshl et al., 1985]. W e used a commercial kit available from Kamlya
Biomedical Co. (Thousand Oaks, CA) that also contained Triton X-100,
ascorbate oxidase (EC.1.10.3.3), and lipoprotein lipase (EC.3.1.1.34). We
adopted this extremely sensitive and specific a ssa y to work with a microtiter
plate reader (Molecular Devices Corporation, Menlo Park, CA) [LeClair and
Stone, 1991]. The assay w as not interfered with by ABAP, tocopherol, urate or
ascorbate a t the levels used In the experiments. The LDL used for the assay
ranged from 5 to 30 pi. The blank used for each LDL lipid hydroperoxide assay
w as an aliquot (equal In volume to the LDL sample) of the dialysate obtained at
the sam e time point

Consumption of aloha- and aamma-tocophetol
An allquote of LDL sam ple w as mixed with ethanol containing tocol a s an
internal standard. Alpha- and gamma-tocopherol present in LDL w ere then
immediately extracted Into hexane containing BHT (50 pg/ml). Following the
extraction, the hexane layer w as removed an d then evaporated under a gentle
stream of nitrogen gas. The residue w as dissolved In ethanol containing proryl
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R gure 6. Mechanism of the colorimetric method for lipid hydroperoxide
determination.

galleate (50 |xg/ml) a s an antioxidant Levels of alpha-tocopherol and gammatocopherol w ere m easured using reverse p h ase HPLC with a Ahex-UltrasphereODS (Beckman Instruments, Inc., Fullerton, CA) 4.6 mm ID x 25 cm column
[Bierf et al., 1979]. The mobile phase w as methanol w a te r (99.5%:0.5%,
vol:voi). A McPherson Model FL-750 spectrofluorescence detector (McPherson
instrument, acton, MA) w as utilized with 294 nm excitation and 324 nm
emission. Alpha-tocopherol, gamma-tocopherol and tocol In a 1:1:1 weight ratio
gave peak a re a s with a 1.796:0.798:1.000 ratio using the fluorescent detector.
Correction factors were, therefore, used to convert peak a re a s to nmotes of
alpha- or gamma-tocopherol.

Determination of Ascorbate end Urate Concentration
The concentration of ascorbate and urate In the dialysate from each
oxidation system w as determined by recording the UV spectra with a Milton
Roy Model 3000 photodiode array spectrophotometer (Milton Roy Co., Marietta,
GA). An extinction coefficient of 15,000 cnV’M*' at 265 nm [Lewin, 1976] w as
used for ascorbate and 11,220 cm‘1M 1 at 292 nm for urate.

For each human LDL oxidation experiment, the linear regression
coefficients for time versus lipid hydroperoxide formation before and after the
induction period w as calculated using Sigma Plot Scientific Graph System
(Jandel Scientific, Corte Madera, CA, USA). Standard statistical m ethods were
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employed to determine If the elopes, I.e., the rates of lipid hydroperoxide
formation, were significantly different before an d after the induction period
[Edwards, 1979], The induction period w as the time required to totally consum e
all tocopherol. The m ean rates of lipid hydroperoxide formation from the six
independent LDL oxidation experiments (In the presence or absence of urate or
ascorbate) w ere also com pared by a one-way analysis of variance (ANOVA)
followed by Scheffe’s test for comparing multiple m eans. A p < 0.05 was
considered a s statistically significant.
The consumption of alpha-tocopherol and gamma-tocopherol for each
oxidation experiment w as curve fit by nonlinear regression using the MarquardtLevenberg algorithm provided by Sigma Plot Scientific Graph System . The
modified sigmoidal equation (1) gave the best fit (see Results),
toe (I) « (toe0 + bt)/(1+(t/c)d)

(1)

The curve fit algorithm also provided the standard error for each parameter.

Part II - The Role of Dietary Fat and Vitamin E on R at Plasm a Oxidation

Overall Experimental Design
Male Fischer-344 rats w ere fed diets supplem ented with or deficient In
vitamin E (alpha-tocopherol) and containing high levels of either com oil or
butter oil. Plasm a w as collected and pooled from rats In different dietary group.
Plasm a oxidation w as Induced by either water soluble azo-inltiator (ABAP) or
lipid soluble azo-lnltiator (AMVN). During oxidation, the lipid hydroperoxide

formation w as m easured cdorimetrically a s a function of time. The alphatocopherol consumption In plasm a from rats fed vitamin E supplemented diets
w as determined by reversed phased HPLC. Plasm a fatty a d d composition,
plasm a levels of triglyceride, cholesterol, ascorbate, urate and sulfhydryl group
In Individual rats were m easured. Plasm a lipids from individual rats were
extracted and analyzed for lysolecithin and plasmalogen content using thin layer
chromatography (TLC).

C h e m ic a ls

2,2'-Azobis (2-amldinopropane) HCL (ABAP) and 2,2’-azo*bJs (2,4dimethylvaleronitrile) (AMVN) w as obtained from Pofysdences, Inc. (Warrington,
PA). Monobasic or dibasic sodium phosphate, cholesterol esterase, HR
peroxidase, cholesterol oxidase, 5,5’-dithIobls*(2-nitrobenzoid add) (DTNB),
cum m ene hydroperoxide, trichloracetic a d d , ascorbate oxidase, phenazine
methosulphate, 3*(4,5-dimethytthiazolyl-2)-215-diphenyitetrazolium bromide
(MTT), triton X-100, cupric sulfate and boron trifluoride w ere obtained from
Sigm a Chemical Company (S t Louis, MO). Sodium sulfate, chloroform,
dichtoromethane, methanol, ammonium hydroxide (NH4OH) were purchased
from Fisher Sdentitle (Fair Lawn, NJ). All chemicals w ere used a s they cam e
without further purification.

Animals and Diets.
Male Fischer-344 rats weighing 50-60 g were obtained from Charles

River’s Breeding Laboratories (Wilmington, MA). Rats w ere housed in
suspended stainless steel wire-bottomed cag es at 25 ± 2°C and 50% relative
humidity and maintained on a 12 hr light-dark cycle. For the first two weeks,
the rats w ere fed a nonpurified diet (Rodent Laboratory Chow 5001, Ralston
Purina Co., St. Louis, MO) and tap water ad libitum. Rats were then randomly
divided into four dietary groups (8 rats/group): (1) com oil diet supplemented
with vitamin E (CQ+E); (2) com oil diet deficient in vitamin E (CO-E); (3) butter
oil diet supplem ented with vitamin E (BO+E); (4) butter oil diet deficient in
vitamin E (BO-E). T he composition of the CO-E diet Is listed in Table 1. The
vitamin E deficient diets contained all other necessary nutrients a s proposed by
the National R esearch Council [National R esearch Council, 1978J. Vitamin E
(RRR-aipha-tocopherol) and com oil (tocopherol stripped) w ere kindly provided
by Eastm an Chemical Company (Kingsport, TN). The tocopherol and
cholesterol free butter oil were obtained from Source food Technology, Inc.
(Burnsville, MN). All other dietary supplies, i.e., torula yeast, sucrose, vitamin
mix, salt mix, L-methionine and cholesterol w ere purchased from United States
Biochemical Co. (Cleveland, Ohio). Food consumption in each dietary group
w as m easured and adjusted every two days so that all rats consum ed the sam e
amount of food each week. Rat body weight w as recorded every four weeks.

P rep aratio n o fR at Diets
Various rat diets were prepared In small batches (2.7 kg) every two
weeks by slowly mixing the constituents to avoid heating, and stored at 4°C in
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Table 1. Composition of CO-E diet

Ingredients

g/1 OOg

Torula yeast

35.35

Sucrose

42.00

Com oil, tocopherol stripped

14.50

Vitamin mix1

2.90

Mineral mix draper2

3.95

L-Methlonine

0.25

Cholesterol

1.00

Selenium (0.4 ppm)

1

The vitamin mixture provided: (in mg/100g of diet) ascorbic acid, 99;

inositol, 11; choline chloride, 16.S; p-amlnobenzoic acid, 11; niacin, 9.9; ribofla
vin, 2.2; pyridoxine-HCL, 2.2; thiamin HCL, 2.2; calcium pantothenate, 6.6;
biotin, 0.05; folic add, 0.2; vitamin B12, 0.003. In addition, the vitamin mixture
contained: (in untts/100 g of diet) vitamin A acetate, 1980; calciferol (D3), 220.
3

The salt mix provided On mg/100 g of diet): C aC 03, 654; 00804*51-120,

0.72; Ca3(P 0 4)2, 1422; ferric citrate

64; MnSC^-HaO,5.5; potassium

c itra te ^ O , 946; Kl, 0.16; KaHP04, 309; NaCI, 432; Z hC 03, 1.8; and MgC03l
164.
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air tight plastic containers purged with argon. To prepare vitamin E
supplemented diets (CO+E or BO+E), an aliquot of alpha-tocopherol (100
I.U./kg diet) w as dissolved In small amount of ethanol (5 ml in 400 mg oil), then
mixed gently with com oil or butter oil. The sam e am ount of ethanol w as added
to com oli or butter oil when vitamin E deficient diets (CO-E or BO-E) w ere
made.

C o lle c tio n o f R a t P l a s m a

R ats w ere lightly anesthetized with metofane (2,2-Dlchloro-1,1-dlfluoroethyl methyl ether). A small segm ent from the end of each rat's tail w as cut off
with a sterilized razor blade. Blood w as collected in a 1.5 ml Eppendorf
mlcrofuge tube containing 30 pi of UaJEDJA (75 mg/ml) a s anticoagulant and
centrifuged at 15,600 x g for 10 min a t 4°C in an Eppendorf centrifuge (Brinkm ann Instruments, Inc., Westbury, NY). Plasm a w as collected and assay ed for
ascorbate an d urate level within 2 hours. Plasm a from rats In the sam e dietary
group w as pooled and used for oxidation experiments within two days. An
aliquot of plasm a w as frozen a t -80°C and used for determination of fatty a d d
composition, triglyceride and cholesterol, a s well a s analysts of phospholipid
composition.

Fattv Add Composition of Plasm a
An aliquot of rat plasm a w as transesterifled with boron trifluoride In
methanol by heating for 15 min at 80°C. Fatty a d d C21 w as used a s an

internal standard. After addition of distilled water, fatty acid methyl esters
(FAMEs) w ere extracted with hexane. The hexane extract w as evaporated
under nitrogen and the residue taken up in dichtoromethane. Fatty a d d methyl
esters w ere analyzed by g a s chromatography (Vartan, model 3700) equipped
with a SP™-2330 glass capillary column (60 m eters long and 0.75 mm ID)
(Supelco, Bellefonte, PA). The tem peratures at the Injection port and the
hydrogen flame Ionization detector w ere 230°C and 260°C respectively. The
initial tem perature at the column w as 140°C and final tem perature w as 210°C at
an increasing rate of 3°C/min. Nitrogen w as used as a carrier gas.

Determination of Triatvceride
Plasm a triglyceride levels from Individual rats w ere m easured
enzymatically according to the method of Bucolo and David [Bucoto and David,
1973]. A commercial kit obtained from Sigma Diagnostics (St. Louis, MO) w as
adopted to work with a microtiter plate reader (Molecular Devices Corporation,
Menlo Park, CA). In this assay, plasm a triglycerides w ere hydrolyzed by
lipoprotein lipase to glycerol and free fatty a d d s. The glycerol w as then
coupled with enzym e reactions catalyzed by glycerol kinase, glycerol-1 phosphate dehydrogenase and dlaphorase. The resulting formazan had an
absorbance at 490 nm. The Intensity of the color produced w as directly
proportional to the triglyceride concentration of p lasm a The concentration of
triglyceride w as calculated based on the absorbance of the blank, plasm a and
calibrator (Sigma Diagnostic, S t Louis, MO) using the following equation:
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triglycerides (mg/dl) =[(Apt-m- - At* J/(A olltnto, - A***)]
♦(concentration of calibrator)

Determination of Cholesterol
R a sm a total cholesterol from individual rats w as determined by an
enzymatic method [Allain et al.t 1974; Zoppi and Fentlft 1976] using a microtiter
plate reader (Molecular Devices Corporation, Menlo Park, CA). Cholesteryl
esters were hydrolyzed by chotesteryl ester hydrolase to free cholesterol and
fatty acids. Free cholesterol w as oxidized by cholesterol oxidase and the
resulting hydrogen peroxide coupled with the peroxldase/phenot/4aminoantipyrine system . The resulting quinoneimine product w as m easured at
500 nm. The plasm a concentration of cholesterol w as determined relative to
free cholesterol standard curve.

Rat Plasm a Oxidation
Two types of azo-Initiators w ere used to Initiate rat plasm a oxidation, one
is water soluble (ABAP), the other is lipid soluble (AMVN).

R a sm a Oxidation Initiated bv ABAP. R a sm a (1.5 ml) from rats fed the
sam e diet w as pooled and placed In bottom flat glass vials with cap s open.
Oxidation w as started by addition ABAP (the final concentration of ABAP w as
25 mM) into plasma. R asm a with ABAP w as incubated a t 30°C and exposed
to the air. At different time points, tipld hydroperoxide and vitamin E levels
w ere determined by the methods described in the section 'lipid hydroperoxide
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measurement" and "consumption of alpha- and gamma-tocopheroi".
R a sm a Oxidation Initiated bv AMVN. Plasm a from rats fed the sam e
diet w as pooled and diluted with phosphate buffer saline (PBS) (1:1, v/v). The
oxidation w as performed a s described above for the w ater soluble azo-initlator
except 10 mM AMVN w as used and plasma w as incubated at 37°C instead of
30°C. Preliminary experiments indicated that the experimental conditions for
the plasm a oxidation initiated by AMVN, i.e., dilution of plasm a and tem perature
of plasm a Incubation (37°C), are appropriate for studying the oxidation kinetics
in the presence of AMVN, because the oxidation kinetics can be observed
within a reasonable time (8 to 10 hours).

D e te rm in a tio n o f A s c o r b a te

The ascorbate a ssa y w as performed within 2 hours after blood collection.
The plasm a ascorbate levels in individual rats w ere determined colorimetricalfy
in a microttter plate reader (Molecular Devices Corporation, Menlo Park, CA) by
a modification of the Beuteler method [Beuteler, 1984]. Rat plasm a (200 pi)
w as mixed with 10 pi 3.0 M of trichloroacetic a d d and centrifuged at 10,000
rpm. The supernatant w as mixed with phosphate buffer (0.5 M, pH 7.5) and
tetrazolium salt (MTT). In sam ple blank, ascorbate oxidase (637.5 kU/l) w as
added to rem ove ascorbate In plasma. After incubating for 6 minutes at 37°C,
the absorbance at 578 nm was recorded a s A,. The 5-methylphenazJnium
m ethosulphate solution (PMS, 15 mM) w as added and mixed with both sam ple

and sam ple blank, and then Incubated at 37°C for another 15 minutes. In this
reaction, ascorbate reduced the MTT to a formazan in the presence of PMS.
The absorbance (Aj) at 578 nm w as recorded immediately. The absorbance
change

- A, *«*) of the blank w as subtracted from the absorbance

change of the plasm a (A ^ ___ - A, p.mTt). The absorbance difference w as
proportional to the ascorbate level In the plasma. L-ascorbate w as used a s a
standard for determining the concentration of ascorbate in the plasma.
Urate M easurement In Rat Plasm a
Urate content In Individual rats w as determined enzymatically using a uric
acid determination kit (Sigma diagnostics, S t Louis, MO). The uric a d d w as
oxidized by urlcase to becom e attantotn, C 0 2 and HL,02. The HjO, reacts with
4-amlnoantipyrine and 3,5-dichloro*2-hydroxybenzenesutfonate to form a
qulnoneimtne dye which absorbs at 532 nm. This com m erdal kit w as adopted
to a microtiter plate reader (Molecular Devices Corporation, Menlo Park, CA).

Sulfhvdrvl Group (SH4 Assay
Sutfhydryl concentrations in plasma from rats fed various dietary groups
were m easured according to the method described by Elm an [Ellman, 1959].
The assay w as performed In a microtiter plate with 5,5'*dithiobis (2-nitrobenzoic
add) (DTNB) a s follows: 30 pi of plasm a w as mixed with 270 pi of 0.2 M
NajHPO* (pH 9.0, containing 2 mM EDTA) and 20 pi of DTNB stock solution
(10.0 mM In 0.035 M phosphate buffer a t pH 7). The absorbance at 412 nm

4

36
w as m easured. L-cystelne w as used a s a standard.

Cummene Hydroperoxide Consumption In Plasm a
An aliquot of rat plasm a w as placed In a Eppendorf microfuge tube at
30°C water bath. Cummene hydroperoxide w as dissolved in a small am ount of
ethanol and then added to 10 mM PBS to obtain a PBS stock solution. The
stock solution of cum m ene hydroperoxide w as added to the plasm a giving a
final concentration of 1 mM. The concentration of cum m ene hydroperoxide in
plasm a w as m easured a s a function of time by the method described under the
method of m easurem ent of lipid hydroperoxides. PBS containing 1 mM of
cummene hydroperoxide w as used a s a positive control.

Uoid Extraction of Plasm a
Rat plasm a (500 pVrat) w as extracted by th e modified m ethod of Bifgh
and Dyer [Bligh and Dyer, 1959] using methylene chloride Instead of chloroform
[van Kuijk, 1965]. The solvent used during extraction w as 2 ml methanol, 2 ml
dichloromethane containing 50 pg/ml BHT (2:1, v/v). The dlchloromethane
p h ase containing lipids w as dried over sodium sulfate and evaporated in a Vlrtis
model 10-030 freeze dryer (the Vlrtis Company, Inc. Gradiner, NY). The lipid
residual w as resuspended In chloroform and stored at 4°C.
Phospholipid Analysis bv TLC
Phospholipids of rat plasma and liver were separated by unldlmentional
thin layer chromatography (TLC) by the method of Sherm a and Touchstone

[Sherma and Touchstone, 1978]. W hatman LK5D precoated silica gel plates (5
x 20 cm) were obtained from Fisher Scientific (Fair Lawn, NJ). T hese plates
contain a layer of 80

A silica gel above a

3 cm Inert preadsorbent layer, and

are scored Into 9 mm wide lanes in the long direction. The layers were pre
washed in chloform:methanol (1:1, v/v) and then oven dried a t 130°C for 15
minutes. The lipid extracts were spotted on the preadsorbent area, then
developed in an unsaturated glass tank. The mobile p h ase w as ethyl acetate:
n-propanol: chloroform: methanol: 0.25% aqueous KCJ (25:2525:13:9 v/v). The
mobile phase w as allowed to ascend to the top of the plate. The
chromatogram w as air dried for 15 minutes, sprayed heavity with a solution
containing 10% CuSO« and 8% H3P 0 4. The lipids were visualized by heating
the plate a t 170°C-180°C for 15 minutes. Phospholipid standards (Matreya,
Inc., Pleasant gap, PA) were used to identify each phospholipid subclass in rat
plasma. The amount of each phospholipid w as determined by measuring the
a reas of spots using a scanner and Sigma S can Image analysis software
(Jandel Scientific, Corte Madera, CA). The area of each lipid subclass w as
interpreted a s a percentage of the area of total phospholipids.
Statistical Analysis
A one-way or two-way ANOVA followed by Scheffe's test w as used to
compare the fatty a d d composition, plasm a concentration of cholesterol,
triglyceride, sulfhydryl group, ascorbate and urate in rats fed various diets. A p
< 0.05 w as considered a s statistically significant.

CHAPTER 3
Results
Part I - The Influence of Plasm a Antioxidants on the Oxidation
Kinetics of Human Lipoprotein

The Consumption of Tocopherol During LDL Oxidation
Alpha- and gamma-tocopherol are the major forms of tocopherol present
In human LDL (see Figure 3). Figure 7 show s the HPLC chromatograms of
tocopherol extracted from LDL oxidized with 15 mM ABAP at 30°C. Alphatocopherol (peak #3) w as consum ed more rapidly than gamma-tocopherol
(peak #2), i.e., when LDL had been oxidized for 3.5 hours m ost of alphatocopherol disappeared while gamma-tocopherol rem ained almost unchanged.
Gamma-tocopherol w as consum ed only after most of the alpha-tocopherol w as
oxidized. Eventually, both alpha- and gamma-tocopherol w ere depleted. Tocol
(peak #1), an internal standard, remained constant from one run to another.

The Rate and Efficiency of Uotd Peroxidation Chain Initiation
Azo-initiators a re particularly useful for studying the oxidation of organic
molecules because they provide quantitative kinetic Information. ABAP (A-N=NA where A*= HCINHsCtCH^) is thermally labile and decom poses (see equation
2) unimotecuiarty to generate free radicals (A4) at a known constant rate. At
30°C the rate of decomposition is equal to [ABAP]*k, where k,= 3.82 x 10‘7/sec
38
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Rgure 7. The chromatogram of tocol (paok #1), gamma-tocopherol (paak #2)
and aJpha-tocopberol (paak #3) separated by reverse phase HPLC using a
fluorescent detector. Tocol was used as an internal standard.
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at 30°C [Barclay, 1984].
A*N=N*A —> 2A* + Nj

(2)

Not all the radicals generated by reaction (2) are, however, able to
Initiate lipid peroxidation chain reactions. The actual rate of chain Initiation, R,,
can be estim ated from equation (3) where tj Is the induction time, i.e., the time
required to consum e all the tocopherol (alpha- plus gamma-tocopherol) present
in an LDL sample.
R, = 2[tocopheroiJ/tj

(3)

R gure 8 shows the oxidation of a typical hum an LDL sam ple in the
presence of an air saturated solution containing 15.0 mM of the w ater soluble
azo-initiator ABAP a t 30°C (no ascorbate or urate). For the d ata given In Figure
8, R, w as 1.35 x 10* M/sec. The efficiency, e, at which the A* radicals initiate
(ipid peroxidation chain reactions is given by equation (4).
e = R, / 2k,([A-N=N-AD

(4)

For the data In Rgure 8, th e efficiency, e, w as 0.23. The m ean efficiency for all
five LDL oxidation experiments w as 0.51+0.13 which is very simitar to the value
found by others for the autoxidation of linoleic a d d in SDS micelles at 30 CC
using ABAP [Ohishl, 1985].

Lipoprotein Oxidation In the Absence of W ater Soluble Antloxidants
R gure 8 show s that while alpha- and gamma-tocopherol w ere present
(I.e., during the induction period) the rate of lipid hydroperoxide (LOOH)
formation in LDL w as stow but linear with time. W hen ait the alpha-tocopherol
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Rgure 6. Tocopherol consumption and tipid hydroperoxide formation in human
LDL exposed to 15 mM water soluble free radical initiator ABAP in the absence
of ascorbate or urate. One experiment typical of six is shown.

and gamma-tocopherol were consum ed (about 2 hrs) the rate of lipid
hydroperoxide formation significantly increased and remained linear. The rate
of lipid hydroperoxide formation also provides an estim ate of the chain length,
v, which is a m easure of the number of propagations per initiation
[Barclay,1984]. A number greater than one indicates that LDL oxidation
proceeds via a free radical chain mechanism. For Figure 8, the chain length (v
= (d[LOOH]/dt)/R,) before and after all the tocopherols were consum ed w as 10
and 80, respectively. For all six LDL oxidation experiments chain lengths of 4.0
± 1 .7 and 26.0 ± 11.6, respectively, were found for LDL oxidation In the
absence of either ascorbate or urate.
Lipoprotein Oxidation in the Presence of W ater Soluble Antioxidants
Figures 9 and 10 show the oxidation kinetics of one LDL sam ple In the
presence of 50 pM of ascorbate or 50 pM urate, respectively. The insert In
R gure 9 shew s the consumption of ascorbate during the oxidation experim ent
Stmilarty, the insert in Figure 10 show s the consumption of urate. The rate of
lipid hydroperoxide formation during the Induction period w as com pared for the
LDL sam ple in the absence of w ater soluble antioxidant (Rg. 8), in the
presence of ascorbate (Rg. 9) or urate (Rg. 10). Ascorbate, but not urate,
significantly reduced the rate of llptd hydroperoxide formation during the
Induction period. After all the alpha- plus gamma-tocopherol w as consumed,
however, the rate of lipid hydroperoxide formation w as very similar for LDL
sam ples oxidized under the three conditions (no water soluble antioxidant, 50
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R gure 9. Tocopherol consumption and lipid hydroperoxide formation in human
LDL exposed to 15 mM water soluble free radical initiator ABAP in the presence
of 50 pM ascorbate. One experiment typical of six is shown.

44

1600

protein)

12

so

1400

20

1200
1000

6

T im • ( h r * )

6 00
- 600

4

4 00

2

2 00

0

0

1

2

3

4

5

6

protein)

Tocopherols

6

(nmol/mg

(nmol/mg

10

hydroperoxide

O a —T oe
v y -T o c
• LOOH

Lipid

14

7

Time (h rs)

R gure 10. Tocopherol consumption and lipid hydroperoxide formation In human
LDL exposed to 15 mM water soluble free radical initiator ABAP In the presence
of 50 pM urate. One experiment typical of six Is shown.
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pM initial ascorbate, or 50 pM initial urate). The rates of liptd hydroperoxide
formation In Rg. 8, 9 and 10 is shown in Table 2. Table 3 sum m arizes the data
for all six oxidation experiments. One-way ANOVA of all six oxidation
experiments confirmed the conclusions drawn from th e analysis of a single
oxidation experiment.
Both urate and ascorbate markedly increased the time required to totally
consum e either alpha- or gamma-tocopherol. The length of time required to
consum e alpha- plus gamma-tocopherol w as increased by about 1.5 hr in the
presence of 50 pM ascorbate and by 3.0 hr in the presence of 50 pM urate.
T hese data indicate that urate w as considerably more effective than ascorbate
in delaying the time required for th e consumption of tocopherols. Urate w as
also consum ed at a significantly lower rate (-14,1 pM/hr) than ascorbate (-23.7
pWhr) in the in vitro oxidation system s a s shown by the inserts in R gures 9
and 10.

The Combined Effect of Ascorbate and Urate On LDL Oxidation
R gure 1 1 ,1 2 ,1 3 and 14 show the oxidation kinetics of a different LDL
sam ple. R gure 1 1 ,1 2 ,1 3 shows the oxidation of LDL in the ab sen se or
presence of 50 pM ascorbate or 50 pM urate respectively. Figure 14 show s the
oxidation kinetics of LDL In the presence of 25 pM ascorbate and 25 pM urate.
The Insert in Figure 14 show s the consumption of ascorbate and urate.
Ascorbate w as consum ed rapidly and linearly with time. The rate of ascorbate
consumption w as -24.6 pM/hr which Is very similar to the rate observed for
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Table 2. The influence of ascorbate or urate on rates of lipid
hydroperoxide formation in LOL before and after the induction period (0*
Water-soluble
antioxidant

Rate of lipid hydroperoxide formation
(nmol/mg/hr)
before t,

after t,

none

41.2*4.3*

312.0*17.6?

50 pM Ascorbate

23.9±6.0b

319.0*11.2?

50 pM Urate

45.3*2.7*

305.5*29.9?

‘LDL isolated from an individual donor was oxidized in the presence of 15 mM
ABAP a s indicated in the text. Data are expressed a s mean±SEM. Values not
sharing a common letter (a,b,c,d) are significantly different at p < 0.05.
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Table 3. Summary of rates of liptd hydroperoxide formation In six LDL
sam ples before and after the Induction period (t)*
Water-soluble
antioxidant

Rate of lipid hydroperoxide formation
(nmol/mg/hr)
before t,

after t,

none

54.0*8.1*

236.2*36.2?

50 pM Ascorbate

16.2*11.5b

226.0*32.4"

50 pM Urate

37.1*3.1*

206.6*29.1"

‘Data are expressed a s mean±SEM of six independent oxidation experiments.
Values not sharing a common letter (a.b.c.d) are significantly different at p <
0.05.
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Figure 11. Oxidation kinetics of human LDL isolated from a different donor.
LDL w as exposed to 15 mM water soluble free radical initiator ABAP in the
ab sen ce of ascorbate and urate.
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Rgure 12. Oxidation kinetics of human LDL In the presence of 50 pM
ascorbate. LDL was Isolated from the same donor In FIg.11 and exposed to 15
mM water soluble free radical Initiator ABAP.
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Figure 13. Oxidation kinetics of human LDL In the presence of 50 pM urate.
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Rgure 14. Oxidation kinetics of human LDL in the presence of 25 pM
ascorbate and 25 pM urate. LDL was isolated from the sam e donor In Flg.11
and exposed to 15 mM water soluble free radical initiator ABAP.

ascorbate in the absence of urate. Before ascorbate w as completely depleted
(within 1 hr), urate w as consumed very slowty (the consumption rate w as only 0.8 pM/hr). After ascorbate completely disappeared, urate w as consum ed more
rapidly. The consumption rate w as -12.1 pW hr which is similar to rate of urate
consumption observed In the absence of ascorbate. In the presence of
ascorbate (within 1 hour), both alpha- and gamma-tocopherol levels remained
unchanged, which w as similar to the observations for LDL oxidation In the
presence of ascorbate alone a s shown In R gure 9 and R gure 12. After
ascorbate w as consumed, th e oxidation kinetics was similar to that in the
presence of urate alone a s shown in R gure 10 and 13. The combined effect of
25 pM ascorbate and 25 pM urate on delaying the time required for the
consumption of tocopherots w as more pronounced than that of 50 pM
ascorbate alone but less effective than that of 50 pM urate alone, I.e., 4.0 hrs
with 50 pM ascorbate (Rg.12), 5.5 hrs with 50 pM urate (Rg.13) and 4.5 hrs
with 25 pM ascorbate plus 25 pM urate (Rg.14). Table 4 sum m arizes the rates
of lipid hydroperoxide formation in Rgure 1 1 ,1 2 ,1 3 and 14. The rate of lipid
hydroperoxide formation In the presence of 25 pM ascorbate and 25 pM urate
w as similar with that In the presence of 50 pM urate alone. Both of th ese rates
were significantly different from those in the absence or presence of ascorbate
(P<0.05).

The Curve Rt For Tocopherol Consumption
W e found that the consumption of alpha- or gamma-tocopherol a s a
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Table 4. The combination effect of ascorbate and urate on rates of lipid
hydroperoxide formation In LDL before and after the induction period (t,)*
Water-soluble
antioxidant

Rate of lipid hydroperoxide formation
(nmol/mg/hr)
before t,

after t,

none

46.215.2*

^ .$ ± 3 .8 *

50 pM Ascorbate

22.8±3.0b

127.8±6.7d

50 pM Urate

34.4*0.7*

122,7±2.6d

25 pM Asc+25 pM Urate

31.7±2.3e

122.8±3.6d

*LDL isolated from a different Individual donor w as oxidized in the presence of
15 mM ABAP a s indicated In the text. Data are expressed a s mean±SEM.
Values not sharing a common tetter (a,b,c,d) are significantly different a t p <
0.05.

function of time could b e curve fit to the modified sigmoidal equation, toc(t)=
(toe0 + bt)/(1+(t/c)d), where toc(t) is the tocopherol (alpha- or gamma-)
concentration at time t; toc° is the initial tocopherol concentration; b is the slope
of the tocopherol consumption before its rapid oxidation phase; c is the time at
the inflection potnt for tocopherol consumption and d is a slope param eter
during the rapid phase of tocopherol oxidation. This equation provided an
excellent fit for LDL tocopherol consumption both In the presence or absence of
water soluble antioxidants and w as used to obtain the curves shown in Figures
8-14. In general the values of the d slope param eter were between 5 and 18
for all six LDL oxidation experiments. This implies that for time points before
the Inflection point, c, the term (t/c)d Is small and equation (1) can be
approximated by toc(t) « toe0 + bt, i.e., the consumption of tocopherol is
approximately linear with time and the rate of linear consumption is given by the
b param eter. A more negative value of b indicates a greater rate of tocopherol
consumption before Its rapid oxidation. At the inflection time point, c, equation
(1) can b e reduced to toc(c)n(toc° + bc)/2, i.e., the tocopherol concentration is
half its initial value minus the linear consumption of tocopherol that occuned up
to the inflection point.
Table 5 provides the linear slope parameter, b, and the inflection point
param eter, c, obtained for alpha-tocopherol and gamma-tocopherol
consumption for the d ata presented in Rgure 8, 9 and 10. The linear
consumption of alpha-tocopherol or gamma-tocopherol in the presence of either
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Table 5. The curve fit param eters for tocopherol consumption in the presence
or ab sence of ascorbate or urate*
Water-soluble

c

linear consumption

inflection

(nmoles/mg/hr)

time (hr)

None

-4.42*0.16*

0.99*0.11*

50 pM Ascorbate

-0.01 ±0.08"

2.07*0.01b

50 pM Urate

-0.95*0.05°

3.67*0.03°

none

-0.66*0.07*

1.33*0.02*

50 pM Ascorbate

-0.08*0,03hc

2.65*0.02**

50 pM Urate

•0.16*0.03°

4.25*0.04°

antioxidants

Alpha-

b

Tocopherol

Gamma*
Tocopherol

*Values a re param eter ± SE from curve fit. The b param eter is the slope of the
tocopherol consumption before its rapid oxidation; c is the time at the inflection
point for tocopherol consumption. For each tocopherol, the values in a column
without a common letter (a,b,c,d) are significantly different (p <0.01)

ascorbate or urate w as markedly lower than In the absence of th e se water
soluble antioxidants. Ascorbate w as more effective than urate in reducing the
linear rate of alpha-tocopherol consumption. The linear rate of alpha-tocopherol
consumption, either in the absence of water soluble antioxidants or In the
presence of urate, w as greater than that of gamma-tocopherol. In the presence
of ascorbate the linear consumption of both gamma- and alpha-tocopherol were
found to be very low and not significantly different The inflection point data
provided In Table 5 reinforces the qualitative conclusions drawn from the
induction time periods. Urate (50 pM) tripled and ascorbate doubled the
Inflection time point for alpha-tocopherol observed In the absence of water
soluble antioxidants. The inflection time points for gamma-tocopherol were
always greater than that of alpha-tocopherol.

Part II - The Role of Dietary Fat and Vitamin E on Rat Plasm a Oxidation
Plasm a was isolated from age-m atched male Flsher-344 rats fed diets
either supplem ented (+E) or deficient (-E) in vitamin E and containing either
tocopherol stripped com oil (CO) or butter oil (BO) a s the source of dietary fat
(see table 1).
Food Consumption and Body Weight
Rats in each dietary group were given the sam e amount of food. The
food consumption was 10.5-11.5 g/day/rat and was not influenced by the age of
rats. The mean body weight of rats fed CO-E, CO+E, BO-E and BO+E diets

w ere almost identical at all time points (Fig. 15). Plasm a vitamin E (alpha*
tocopherol) level In rats fed various diets are given In Figure 16. R ats fed
vitamin E deficient diets (CO-E or BO-E) for 5 weeks showed undetectable
vitamin E in their plasma. Plasm a from rats fed BO+E diets had higher vitamin
E content compared to rats fed CO+E diets. There w as a significant difference
in vitamin E levels between CO+E and BO+E by two-way ANOVA (p<0.05).

Fattv Acid Composition. Triotvceride and Cholesterol Levels
Plasm a from rats fed com oil diets (CO-E or CO+E) show ed significantly
higher levels of polyunsaturated fatty a d d (PUFA), lower levels of saturated
fatty a d d (SFA), and lower levels of monounsaturated fatty a d d (MUFA),
compared to plasm a from rats fed the butter oil diets (BO-E or BO+E) (Table
6). The fatty a d d composition of plasm a shown In Table 6 w as similar with that
of dietaiy fat (com oil or butter oil) (data not shown). The plasm a content of
C20:4n6 In rats fed com oil diets w as slightly higher than that in rats fed butter
oil diets, the statistical analysis (two-way ANOVA), however, showed only a
marginally significant difference (p=0.06). The predominant plasm a PUFA from
rats fed CO diets w as C 182n6, which w as about three fold higher compared
with rats fed the BO diets. The ratios of PUFA/(SFA+MFA) in plasm a from rats
fed CO-E and CO+E diets were three fold higher than that observed for plasm a
in rats fed BO-E and BO+E diets. Vitamin E, however, did not influence the
fatty acid composition, I.e., there w as no significant difference for each type of
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Figure 15. Body weights (mean±SEM) of rats fed various diets. There w as no
significant difference am ong m ean body weights of rats at the sam e age.
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R gure 16. Plasm a alpha-tocopherol content (mean±SEM) In rats fed various
diets. Alpha-tocopherol w as m easured by reverse p h a se HPLC. Alphatocopherol In plasma from rats fed vitamin E deficient diets (CO-E and BO-E)
w as undetectable. * Plasm a from rats fed BO+E diets contained significantly
higher vitamin E content than plasm a from rats fed CO+E d iet

Table 6. Effect of dietary fat and vitamin E on rat plasma fatty add composition
PUFA

MUFA
C18:1n9

SFA

Ratio
of
P/S+M

C 182n6 C20:4n6

Cl6:1n9

CO-E (7)

41.5*2.1** 11.2*1.5

2.3*0.3“ 17.8*2.8“

0.3±0.1“ 20.1*1.4“ 6.8*0.9“

1.11“

CO+E (6)

41.1*2.1“ 11.4±1.3

£8*0.7“ 17.9*1.4“

0.2±0.1“ 19.9*1.5“ 6.7*0.7“

1.11“

BO-E (6)

11.7*0.3* 9.3±0.8

5.7±0.4b 28.4±1.9b

2.0*0.2b 30.4*1 .(f

10.5*1.1b

0.27b

BO+E (5)

13.6*0.8? 8.5±0.5

28.4*1.8*

2^±0.2b 30.1*1.3b 10.5*0.9b

0.28b

C14:0

C16:0

C18:0

* Data are expressed a s mean*SEM. Values in a column with different letters are significantly different
ip < 0.05).
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fatty a d d betw een vitamin E supplem ent groups and vitamin E deficient groups.
Figure 17 shows the triglyceride and cholesterol levels in plasm a from
rats fed various diets. Plasm a from rats fed butter oil diets (BO-E and BO+E)
had significantly higher levels of triglyceride and cholesterol than plasm a from
rats fed com oil diets (CO-E and CO+E) (p<0.05). Vitamin E had no effect on
plasma triglyceride and cholesterol levels, I.e., the plasm a content of triglyceride
and cholesterol betw een CO-E and CO+E or between BO-E and BO+E w as not
significantly different.

P h o s p h o lip id C o m p o s itio n

Figure 18 shows the plasm a composition of phospholipids, i.e.,
phosphatidyl ethanotamlne (PE), phosphatidyl Inositol (PI), phosphatidyl choline
(PC), sphingomyelin (SPH) and lyso-phosphatidyl choline (Lyso-PC). PC was
the major phospholipid In plasm a from rats fed various diets. The plasm a
content of PE, PI, PC and SPH w as not significantly different In rats fed various
diets. Two-way ANOVA show ed plasm a lyso-PC contents were influenced by
dietary fat-type, I.e., the m ean lyso-PC content (16.0%±0.6) In plasm a from rats
fed com oil diets (16.1% for CO-E, 15.8% for CO+E) w as higher than that
(13.4%±0.6) in plasm a from rats fed butter oil diets (13.7% for BO-E and 13.1%
for BO+E) (p<0.05). The significant difference was, however, not se en in
Individual dietary group, l.e., lyso-PC level In CO-E (or CO+E) w as not different
than that In BO-E (or BO+E). Dietary vitamin E did not influence plasm a levels
of lyso-PC,
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Figure 17. Triglyceride and cholesterol levels in plasm a from rats fed various
diets. Triglyceride and cholesterol w ere determined by enzymatic method. Data
are expressed a s mean±SEM. * Values not sharing a common symbol were
significantly different a t p<0.05.
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Plasm a Levels of W ater Soluble Antioxidants
We determined if dietary fat or dietary vitamin E could influence the
levels of w ater soluble plasma antioxidants and thereby influence the kinetics of
plasma oxidation. Table 7 sum m arizes the plasma levels of water soluble
antloxidants, i.e., ascorbate, urate and sulfhydryl group, in rats fed various
diets. Neither dietary fat nor vitamin E influenced the plasm a content of these
arrtioxidants. There w as no statistically significant difference among the m eans
for each antioxidant.
Plasm a Oxidation Initiated bv a W ater Soluble Azo-initiator
Figure 19 shows the oxidation kinetics of plasma from rats fed com oil
diets (left panel) and butter oil diets (right panel). The oxidation w as initiated by
addition of a water soluble azo-initiator, ABAP at 30°C to give a final
concentration of 25 mM. Vitamin E w as only detected in vitamin E supplement
ed groups (CO+E or BO+E). The lipid hydroperoxide formation In plasma from
rats fed various diets w as linear with time. A t-test for comparing two slopes of
linear regression w as used to com pare the rates of lipid hydroperoxide
formation In an experiment typical of three (see Rg. 19). The rates of lipid
hydroperoxide formation (see Table 8) In plasm a from rats fed butter oil diets
(BO-E or BO+E) w ere markedly suppressed compared to the plasm a from rats
fed com oil diets (CO-E or CO+E). Surprisingly, plasm a from rats fed vitamin E
supplem ented diets (C+E or B+E) showed higher rates of lipid hydroperoxide
formation than those In plasm a from rats fed vitamin E deficient diets (C-E or B-
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Table 7. Plasm a levels of water soluble antioxidants In rats fed various diets*
Dietary
Group (N)

Ascorbate (pM)

Urate (jiM)

Sulfhydryl group (pM)

CO*E (4)

30.7*1.9

28.2*2.2

111.6*15.1

CO+E (4)

33.6±2.9

29.8*5.5

106.4*28.3

BO-E (4)

22.0*1.7

32.8*2.7

149.9*11.1

BO+E (4)

27.7*3.9

21.0*2.4

125.8*11.0

* Data are expressed a s mean±SEM. There w as no significant difference
among m eans for each antioxidant.
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Table 8. The Influence of dietary fat and vitamin E on rates of lipid
hydroperoxide formation in rat plasm a oxidized in the presence of
ABAP f l w ) or AMVN f l W
Rate of lipid hydroperoxide formation
(pM/hr)
^AMVN
CO*E

10.08±1.4*

31.98*1.9*

CO+E

15.70*1.4"

13.06*0.4"

BO-E

3.07*0.5°

5.26*0.4°

BO+E

5.26*0.4'*

2.87*0.3"

'R at plasm a w as oxidized in the presence of either 25 mM ABAP or 10 mM
AMVN a s indicated in th e te x t D ata are expressed a s sfope*SEM. Values
in a column not sharing a common letter (a,b»c,d) are significantly different
at p < 0.05.
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E). The difference among rates of lipid hydroperoxide w as statistically different
(p<0.05) (see Table 8). Simitar observations w ere also found In other two
experiments.
Plasm a Oxidation Initiated bv a Upld Soluble Azo-initiator
The plasma oxidation kinetics initiated by 10 mM lipid soluble azoinitiator, AMVN at 37°C is shown In Figure 20. Vitamin E w as only detected in
vitamin E supplemented groups (CO+E or BO+E). T he tiptd hydroperoxide
formation in plasm a from rats fed various diets w as linear with time. A t-test for
comparing two slopes of linear regression w as used to compare the rates of
lipid hydroperoxide formation in an experiment typical of three (see Fig. 20).
The rates of lipid hydroperoxide formation In plasm a from rats fed butter oil
diets (BO-E or BO+E) (right panel) were markedly inhibited compared to the
plasm a from rats fed com oil diets (CO-E or CO+E) (left panel). Moreover, the
rates of lipid hydroperoxide formation in plasm a from rats fed vitamin E
supplem ented diets (CO+E or BO+E) w ere lower than those in plasm a from
rats fed vitamin E deficient diets (CO-E or BO-E). Table 8 sum m arizes the rate
of lipid hydroperoxide formation during plasm a oxidation in the presence of
ABAP or AMVN. There were significant differences am ong rates of lipid
hydroperoxide formation for each oxidation experiment (p<0.05).
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Figure 20. Rot plasm a oxidation initiated fay 10 mM lipid soluble azo-initiator, AMVN at 37°C. Lipid
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Oxidation of plasma from rats fed com oil diets (high PUFA) either deficient in (C-E) or supplemented with
vitamin E (C+E). Right panel: Oxidation of plasma from rats fed butter oil diets (low PUFA) (B-E or B+E).
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The Ability of Plasm a to Detoxify Uold Hydroperoxides
Plasm a contains an activity that consum es llpfd hydroperoxides. As
shown In Figure 21, cum ene hydroperoxide (100 pM) added to rat plasm a w as
consum ed a s a function of time. This activity w as not, however, Influenced by
vitamin E levels present in plasma, I.e., the consumption of cum ene
hydroperoxide in plasm a from rats fed CO-E diet w as similar to that In plasma
from rats fed CO+E (Figure 21, left panel). This observation w as also
duplicated In plasm a from rats fed BO-E and BO+E diets (Figure 21, right
panel). Dietary fat did, however, Influence the consumption of cum ene
hydroperoxide in plasma. Cum ene hydroperoxide w as consum ed more rapidly
in plasm a from rats fed CO diets (CO-E and CO+E) compared with plasm a
from rats fed BO diets (BO-E and BO+E), i.e., at 40 minutes after cum ene
hydropeorxide w as added to plasma, about 80% of cum ene hydroperoxide In
plasm a from rats fed CO diets w as consum ed, while only 40% of cum ene
hydroperoxide in plasm a from rats fed BO diets was consum ed.
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Figure 21. Cum ene hydroperoxide consumption in rat plasma. Cum ene hydroperoxide (100 pM) was added to
plasm a from rats fed various diets. The concentration of cumene hydroperoxide in plasma was m easured a s a
function of time. PBS contorting 100 pM cum ene hydroperoxide w as used a s a control.

CHAPTER 4
Discussion

The Influence of Plasm a Antioxidants on the Oxidation
Kinetics of Human Lipoprotein
Increasing evidence supports the view that oxidative modifications to LDL
Increase its atherogenicity. Vitamin E, ascorbate, ublquinoMO, lycopene and
beta-carotene are plasm a antioxidants that play a fairly well recognized role in
preventing LDL oxidation. In contrast, the role of urate a s an antioxidant
capable of preventing LDL oxidation is not a s well appreciated [Becker, 1993].
In the first part of this investigation, w e compared th e ability of urate and
ascorbate to protect human LDL from in vitro oxidation.
The Role of Urate and Ascorbate on LDL Oxidation
In this study, urate was found to be more effective than ascorbate (50
pM Initial concentration for both) in prolonging the time required to completely
oxidize alpha-tocopherot and gamma-tocopherol in human LDL subjected to in
vitro oxidation by aqueous peroxyl radicals. The ability of water soluble

antioxidants to inhibit the oxidation of tocopherols is of particular physiological
importance. Only after all tocopherol has been consum ed is LDL oxidized to a
form reported to b e taken up by m acrophages [Jessup e t ai., 1990].
M acrophages In the arterial Intima that have taken up large amounts of
oxidatively modified LDL are thought to give rise to the foam celts observed In
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early atherosclerotic lesions.
Urate and ascorbate can both prevent oxidative dam age to LDL by
quenching the aqueous free radicals that could otherwise Initiate lipid
peroxidation chain reactions in LDL Evidence suggests, however, that
ascorbate can regenerate tocopherol from the tocopheroxyl radicals in LDL
[Sato e t al., 1990; Kagan, et al.,1992] but that urate d o es not exhibit this
biochemical property [Sato et al„ 1990]. In the in vitro oxidation experiments
reported here, the amount of tocopherol remaining at any time point represents
the initial amount of tocopherol minus the amount consum ed by oxidation plus
any tocopherol regenerated from the tocopheroxyl radicals. In the presence of
ascorbate (see Figure 9), the consumption of LDL tocopherols and the
formation of lipid hydroperoxides w as very low until most of th e ascorbate was
oxidized. The very low level of tocopherol consumption in the presence of
ascorbate Is certainty consistent with the ability of ascorbate to regenerate
tocopherol from tocopheroxyl radicals.
In contrast, LDL tocopherol consumption and the rate of lipid
hydroperoxide formation in the presence of urate (see Figure 10) w as greater
than in the presence of ascorbate. Nevertheless, urate w as consum ed (see
Insert in Figure 10) a t a markedly slower rate than ascorbate (see insert in
Figure 9) in the in vitro oxidation system. The net result w as that urate w as
more effective than ascorbate in extending the time required to consum e all
LDL tocopherols (see Table 5).
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The combination of 25 pM urate and 25 pM ascorbate w as found to be
more effective on extending the lag phase than 50 pM ascorbate alone but less
effective than 50 pM urate alone (see Figure 14), Moreover urate w as
consum ed slowly while ascorbate w as present (see insert in Figure 14),
Indicating that ascorbate and urate act together in preventing LDL against in
v ito oxidation.

LDL Tocopherols and Other Antioxidants
Alpha-tocopherol w as always present in LDL at higher Initial levels than
gamma-tocopherol. Nevertheless alpha-tocopherol w as always totally depleted
more rapidly than gamma-tocopherol In the in vitro oxidation system (see Table
5 and Figures 8, 9 and 10). T hese data are consistent with the view (c.f. ref
Nlkl, 1987) that alpha-tocopherol rapidly reacts with the gamma-tocopheroxyl
radicals to give alpha-tocopheroxyl radicals and gamma-tocopherol.
There have been several studies attempting to define the relative
importance of various plasm a antioxidants in preventing lipoprotein oxidation.
Som e investigators consider the temporal consumption of antioxidants and the
degree to which they inhibit the formation of lipid hydroperoxide to be of primary
importance. It is known, for example, that ubiquinol-10 is consum ed more
rapidly, a s a percent of its initial level, than alpha-tocopherol In LDL exposed to
aqueous peroxyl radicals and that ubiqulnol-10 suppresses the formation of lipid
hydroperoxide formation better than alpha-tocopherol [Stocker, e t al., 1991).
Ubtqulnol-10 might, therefore, be considered a more effective antloxldant than

alpha-tocopherol from a physicochemical point of view. It is, however, also
important to consider the plasma concentrations of antioxidants a s well a s their
ability to delay the consumption of LDL tocopherols. Each LDL molecule
contains six to ten molecules of alpha-tocopherol but only about 0.7 molecules
of ubiquinol-10. All 0.7 molecules of ubiqulnoMO molecules are consum ed very
rapidly when LDL is exposed to peroxyl radicals yet the level of alphatocopherol is decreased by only 5-10 percent [Niki, 1987] a t this time point and
would not, therefore, b e converted into hlgh-uptake atherogenic form of LDL

The Importance of Urate
The concentration of urate (300-395 pM) in hum an serum Is much higher
than the level of ascorbate (30-50 pM). Urate contributes about 35-65 percent
of the chain-breaking antioxidant capacity of human plasm a while ascorbate
contributes about 0-24 percent [Wayner e t a)., 1987]. Urate can form stable
coordination complexes with iron Ions and inhibit Fa1*-catalyzed ascorbate
oxidation and thereby stabilize ascorbate in biological fluids [Davies et a)., 1986;
Sevan!an e t al., 1991]. The d ata presented In this investigation supports the
view that urate should be considered a major plasm a antloxldant with the ability
to considerably delay the oxidation of tocopherols in LDL and thereby prevent
the conversion of LDL Into a more atherogenic form.

The Mathematical Model of Oxidation Kinetics of Tocopherols
T he empirical equation presented in this study, describing the oxidation

kinetics of tocopherols in the presence or ab sen ce of water soluble
antioxidants, is useful for the quantitative stu d / LDL oxidation. As described
previously (see Chapter 3, wider the section of The Curve Fit For Tocopherol
Consumption), the equation provides an excellent cun/e fit for LDL tocopherol
consumption. The param eters of the equation can be used to compare the
kinetics of tocopherol consumption when LDL is oxidized both in the absence or
presence of water soluble antioxidants. It is difficult to draw any useful
conclusions concerning the rapid phase of tocopherol oxidation described by
the d param eter (see equation 1), particularly in the ab sen ce of w ater soluble
antioxidants. This w as due to the brief time on the rapid p h ase of tocopherol
oxidation and the resulting large standard error of the d parameter.
Although there w as much variation In the values of the fit param eters
from experiment to experiment, the general conclusions described above from
the data in Figures 8, 9 and 10 could also be m ade within the other individual
oxidation experiments. Other investigators have also noted that the oxidation
kinetics of LDL sam ples from different individuals can show variability. Not all
the factors responsible for this variability In oxidation kinetics have been
identified but the polyunsaturated fatty acid (PUFA) composition of the LDL is
certainly an Important factor.

The Role of Dietarv_Fat and Vitamin E on Rat Plasm a Oxidation
Dietary fat-type may be an important factor influencing lipid peroxidation
in addition to plasm a antioxidants. In the second part of this study, w e studied
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the potential interaction between dietary fat and dietary vitamin E (alphatocopherol) on plasma oxidation.

Characteristics of Rat Plasm a
The diets provided to the Fisher-344 rats resulted in the desired
alterations in both plasm a PUFA and plasma vitamin E. As shown In Table 6,
rats fed com oil diets high In PUFAs had plasm a fatty a d d compositions with a
high content of PUFA com pared with rats fed butter oil diets which have a high
content of saturated fatty a d d s (SFA). This observation is consistent with that
of other Investigators who have also found that fatty acid composition of
lipoproteins w as strongly modulated by dietary fat. For example, LDL isolated
from rabbits fed a variant sunflower oil containing a high content of oleic acid
(C18:1n9, 80%) and a very low content of linoleic a d d (C18:2n6, 8%) w as
highly enriched In oleic a d d and very low in linoleic a d d [Parthasarathy et a!.,
1990]. In a human study, a dietary supplementation of olive oil to
normollpidemic healthy subjects resulted in lipoprotein enriched In oleic a d d
[Avlram and Elas, 1993].
The diets given to rats also result in an alteration of plasm a vitamin E
content Plasm a from rats fed -E diets (CO-E or BO-E) showed an undetectable
amount of vitamin E (see Fig.16). Plasm a levels of vitamin E In rats fed BO+E
diet w ere higher than that in rats fed CO+E diet, despite the fact that the sam e
amount of vitamin E w as added to both the CO+E and BO+E diets and the food
consumption of rats in th e se two dietary groups w as similar. The difference in

plasm a vitamin E content appeared between rats fed CO+E and BO+E diets
may be explained by the different fatty acid contents of the two diets. Vitamin
E is absorbed into enterocytes passively during the process of intestinal lipid
absorption. Vitamin E absorption, therefore, is facilitated by a libera) intake of
fat [Kayden and Traber, 1993]. Rats fed the BO+E diet had higher levels of
plasm a triglyceride than rats fed the CO+E diet, suggesting that In th ese rats,
more vitamin E w as absorbed from the intestine and secreted Into
chylomicrons. Subsequently more vitamin E could be taken up by livers and
secreted Into plasm a lipoproteins. Many studies Indicate that plasm a levels of
vitamin E correlate with total plasm a lipids because vitamin E is transported in
plasm a only by lipoproteins [Bjomson et al„ 1976; Behrens et al., 1982;
Lambert and Mourot, 1984; Behrens and Madere, 1985; Traber and Kayden,
1989]. Patients with lipoprotein lipase deficiency, who have elevated levels of
triglyceride-rich lipoproteins (chylomicrons and VLDL), have about 10 times
higher plasm a level of alpha-tocopherol than normal [Traber et a)., 1985;
Traber, et al., 1992]. Alternatively plasma from rats fed the CO+E diet could
have undergone In vivo oxidation to som e extent due to its high PUFA content.
Another possibility Is that rats fed CO+E and BO+E diets had different
levels of hepatic tocopherol-binding protein. Tocopherol-binding protein
transfers alpha-tocopherol from liver stores to nascent VLDL [Traber et a!„
1990; Traber et al., 1992]. Thus, this protein plays an important role in
regulating plasm a alpha-tocopherol levels by regulating the transfer of alpha-
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tocopherol Into VLDL It Is not known whether or not dietary fat-type influences
the synthesis of alpha-tocopherol binding protein. Further investigation Is
required to determine the levels of alpha-tocopherol binding protein in livers
from rats fed com oil diets or butter oil diets.
Dietary fat-type influenced the plasm a level of triglyceride (TG) and
cholesterol (CHO). As shown in Fig. 17, rats fed PUFAs enriched com oil diets
showed lower plasm a levels of TG and CHO than rats fed butter oil diets. This
observation w as consistent with the view that a diet rich in PUFA reduces
plasm a cholesterol level [Mattson and Grundy, 1985; Ahrens et al., 1957].
Dietary vitamin E content, however, did not influence the plasm a levels of TG
and CHO.

The Role of Dietary Fat on Plasma_Oxldation
In th e se experiments, rat plasm a oxidation w as initiated by two types of
azo-initiator, one w as water soluble, ABAP, another is lipid soluble, AMVN. In
both cases, the rates of lipid hydroperoxide formation in plasm a from rats fed
CO-E and CO+E diets w ere much higher than those In plasm a from rats fed
BO-E and BO+E diets (see Fig.19, Fig.20 and Table 8). T hese results indicate
that plasm a lipids from rats fed com oil diets (CO-E and CO+E) w as much
more susceptible to in vitro oxidation In regardless of whether or not Initiating
free radicals were generated in aqueous region or lipid region. Difference in
plasm a oxidation betw een rats fed the CO or BO diets w as not a result of
difference in the levels of water soluble antioxidants. Plasm a levels of
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ascorbate, urate and sutfhydryt group in rats fed different diets w ere not
significantly different (see Table 7). Moreover, the difference in plasm a
oxidation can not be explained by a difference in the activity of plasm a to
consum e lipid hydroperoxides. As shown in Figure 21, cum ene hydroperoxide
w as consum ed faster in plasm a from rats fed either CO-E or CO+E diets than
that observed in plasma from rats fed BO-E or BO+E d o ts.

The Role of Dietary Vitamin E on Plasm a Oxidation
Vitamin E is the ma]or lipid soluble antioxidant preventing plasm a lipids
against oxidation. In th ese experiments, Figure 20 show s that plasm a from rats
fed vitamin E supplem ented diets (CO+E or BO+E) had tower rates of lipid
hydroperoxide formation when oxidation w as initiated by a lipid soluble azoinitiator, AMVN, com pared with plasm a from rats fed vitamin E deficient diets
(CO-E or BO-E). This result w as consistent with the view that vitamin E
protects LDL from oxidation [Stone e t at., 1986; Jialal and Grundy, 1992;
E sterbauer et al., 1991; Ma et al., 1994]. Vitamin E, however, show ed an
opposite effect when rat plasma w as oxidized by a water soluble azo-initiator,
ABAP. As shown in Figure 19, plasm a from rats fed CO+E or BO+E diets had
higher rates of lipid hydroperoxide formation than plasm a from rats fed CO-E or
BO-E diets. This surprising result can not be explained by difference in plasma
levels of water soluble antioxidants. As shown in Table 7, vitamin E did not
influence the plasm a levels of th ese antioxidants. This observation suggests
that vitamin E can becom e a prooxidant rather than an antioxidant under certain
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circumstances.
R ecent studies have shown that when human LDL w as oxidized under
mild free-radical-initiated conditions, i.e., the initiating free radicals are in low
concentration, alpha-tocopherol accelerated LDL peroxidation, particularly when
LDL oxidation w as initiated by a water soluble azo-initiator, ABAP [Bowry, et al.,
1992]. B ased on their findings, Bowry and Stocker [Bowry and Stocker, 1993]
proposed that alpha-tocopherol (a-tocH) interacts with alkylperoxyl radicals
(ROD*) generated from ABAP (R-N=N-R) and becom e alpha-tocopheroxyl
radical (a-toc-) (see reaction 5 and 6).

Oa
R -N =N -R

* R ----------- » ROO*

ROO* + a*tocH --------- > ROOH + a-toc-

(5)
(6)

W hen ROO* is present in high concentrations, a-toc* can trap a second ROO*
and produce a nonradlcat product (NRP) (see reaction 7).
a-toc* + ROO------------> NRP

(7)

When ROO* is low in concentration, the a-toc* species does not terminate
(i.e., reaction 7) and therefore can interact with PUFA lipids (LH) to produce
lipid peroxyl radicals (LOO*)(see reaction 8 and 9).
a-toc* + LH ----------- > L* + a-tocH

(8)

L *+O a ----------- > LOO*

(9)

The LOO* produced interacts with a-tocH to produce lipid hydroperoxide
(LOOH) and a-toc* (see reaction 10).
LOO* + a-tocH --------- > LOOH + a-toc*

(10)

The a-toc- formed in reaction (10) can propagate iipid peroxidation by
interacting with another LH a s shown in reaction (8). During plasm a oxidation
induced by ABAP, free radicals were generated in the aqueous phase. Plasm a
contains a number of antioxidants to quench the initiating free radicals (reaction
5) before they could a cc e ss to liptd phase. Moreover, initiating free radicals
generated in the aqueous phase would only interact with the surface lipids of
lipoproteins. Thus the flux of radicals having a ccessed to lipid molecules was
low and a-toc* could not find a terminating radical. Under th ese circumstances,
the a-toc* could Initiate lipid peroxyl radical formation with PUFA moieties.
W hen plasm a oxidation w as initiated by lipid soluble azo-initiator, AMVN, free
radicals w ere generated In lipid phase and the entire lipid phase (surface and
core lipids) can be accessed by free radicals and more terminating radicals are
available for a-toc*. In this situation, the concentration of a-toc* would b e low
and, therefore, atpha-tocopherol would act a s a chain-breaking antioxidant to
protect plasm a against lipid peroxidation.

Evaluation of Methods Used to M easure Plasm a Susceptibility to Oxidation
In our experiments, we used a very sensitive method to m easure the
formation of lipid hydroperoxide when plasma oxidation w as initiated either by
ABAP or AMVN. We found that not onty vitamin E but also the PUFA content
of plasm a w as important in influencing the susceptibility of plasm a to in vitro
oxidation. Several m ethods have been developed by other investigators for
determining the susceptibility of plasm a to oxidation. The two main m ethods

are Total Radical-trapping Antioxidant Param eter (TRAP) and Oxygen-Radical
Absorbance Capacity (ORAC) methods. T he TRAP method relies on the time
during which oxygen uptake Is Inhibited by plasm a antioxidants [Wayner et al.,
1985]. This method requires an Q2 electrode to m easure 0 2 consumption and
Is time consuming. The ORAC method Is a fluorescence a ssay based on the
ability of a dye (phycoerythrin) to be oxidized with the consequent loss of
fluorescence [Cao et al., 1993]. This method is very sensitive and requires only
a few microliters of sam ple. In a preliminary study from our lab (performed by
Annong Huang) showed, however, that this assay w as not sensitive to either
the vitamin E or the PUFA content of rat plasma. Both TRAP and ORAC use
only ABAP, a water soluble azo-initiator to generate free radicals. T hese
m ethods therefore primarily m easure the radical-trapping ability of w ater soluble
antioxidants. The results from this study dearly dem onstrated that plasm a
PUFA content Is also an important factor Influendng the susceptibility of plasm a
to oxidation. Both the TRAP and ORAC m ethods are not sensitive to plasm a
PUFA content This study suggests that in order to adequately evaluate the
effect of dietary factors on the susceptibility of plasm a to oxidative dam age, it is
necessary to use both ABAP and AMVN to generate free radicals in different
regions of llpid-protein complexes. Moreover, m easurem ent of lipid
hydroperoxide formation Is a more direct method for evaluating the susceptibility
of plasm a to In vitro oxidation.
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Phospholipid Alterations
Although vitamin E deficiency has been shown to activate phosphollpase
A,, and Inhibit the activity of lectthin:cholesterol acyttransferase (LCAT) (Pappu
et al., 1978], w e did not observe any difference In the plasm a content of
lysolecithln between rats fed vitamin E deficiency diets (CO-E or BO-E) and rats
fed vitamin E supplemented diets (CO+E or BO+E), The dietary fat-type did,
however, Influence the plasm a level of lysolecithin, i.e., the m ean lysoPC
content in rats fed CO-E and CO+E diets w as higher than that In rats fed BO-E
and BO+E diets. The difference w as, however, very small (about 16%).
Preliminary studies from this lab on LDL oxidation (performed by Hal Wang, a
graduate student In the Department of Chemistry and Pediatrics) indicated that
lysolecithln increases the susceptibility of LDL to In vitro oxidation initiated by
w ater soluble azo-initiator, ABAP. It is possible, therefore, that lysolecithln may
contribute to the susceptibility of rat plasm a to oxidation.
Ethanolamine plasmalogen (EtnPm) w as shown to have antioxidant
potential [Vance, 1990]. When phospholipids w as isolated by traditional TLC
method, the EtnPm band appears in the sam e position where phosphotidyl
ethanolamin band is located [Synder, 1972]. As shown in Figure 18, the
plasm a PE content w as low and quite variable among rats fed the various diets.
Moreover, two-way ANOVA analysis showed no significant differences in PE
content am ong rats fed the various diets. Plasm alogen w as not, therefore,
considered to be a fruitful avenue for further investigation.
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Comments on Dietary Fat
It h as long been accepted that diets In which PUFAs are substituted for
SFAs are healthy b ecau se PUFA enriched diets can lower plasm a cholesterol
levels [The National DIet-Heart Study, 1968]. Dietary Intervention studies have
dem onstrated that PUFA enriched diets reduce the risk of coronary heart
disease p a y to n et al., 1969]. It Is possible, however, that LDL In th ese
patients Is more susceptible to oxidative modification but that the beneficial
effect of PUFA enriched diets may com pensate for the increased susceptibility
to oxidation [Parthasarathy, 1990]. The d ata presented In this study
dem onstrate that com oil-enriched diets resulted In plasm a more susceptible to
lipid peroxidation. Butter oil Is more resistant to lipid hydroperoxide formation
but K increases plasm a levels of triglyceride and cholesterol which a re known to
Increase th e risk of coronary heart disease [Castetll, 1986; Kaukola et a!., 1980;
Gotto et al.,1977; Barbir et at., 1988; Austin, 1988]. Recent studies suggest
that diets enriched In olive oil (highly enriched with oleic acid, C18:1) a s a
dietary fat source are particularly beneficial because they not only lower plasm a
cholesterol level but also retard atherosclerosis by decreasing the susceptibility
of LDL to oxidative dam age [Grundy, 1986; Mensink, 1989; Aviram and Elas,
1993]. Moreover, plasm a LDL levels and coronary heart disease rates are low
in countries where oiive oil is used a s a major source of dietary fat [Masana et
al., 1991; Baggio e t al., 1988; Sirtori et al., 1986]. Further Investigations are
required before an olive oil-enriched diet Is recom mended to the public.
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Conclusions
Our results from the second part of this study indicated that low dietary
PUFA levels are more important in preventing the In vitro oxidation of plasm a
lipids than high dietary levels of alpha-tocopherol. Vitamin E w as found to be
protective against lipid peroxidation when plasm a oxidation w as initiated by a
lipid soluble azo-in'rtiator, AMVN. Vitamin E, however, exhibited a prooxidant
effect when plasm a oxidation w as initiated by a water soluble azo-in’rtiator,
ABAP. This study provides useful Information for the design of future
epidemiological or intervention studies related to lipid oxidation and
cardiovascular disease.
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